Pilot Study of Minocycline in Huntington's Disease

NCT00277355 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

114

Enrollment

NETWORK

Sponsor class

Conditions

Huntington Disease

Interventions

DRUG: minocycline
DRUG: Matching placebo

Sponsor

Merit Cudkowicz

Collaborators

[object Object]